Andrew Fire
| Andrew Fire | |
| Born | Andrew Zachary Fire 27 4, 1959 |
|---|---|
| Birthplace | Palo Alto, California, U.S. |
| Nationality | American |
| Occupation | Biologist, professor |
| Title | Professor of Pathology and of Genetics |
| Employer | Stanford University School of Medicine |
| Known for | RNA interference (RNAi) |
| Education | University of California, Berkeley (B.A.) Massachusetts Institute of Technology (Ph.D.) |
| Awards | Nobel Prize in Physiology or Medicine (2006) |
Andrew Zachary Fire (born April 27, 1959) is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. Born in Palo Alto, California—the very city where Stanford is located—Fire would grow up to make one of the most consequential discoveries in modern molecular biology. In 2006, he was awarded the Nobel Prize in Physiology or Medicine, jointly with Craig C. Mello, for their discovery of RNA interference (RNAi), a fundamental mechanism by which cells silence gene expression.[1] Their landmark research, conducted at the Carnegie Institution of Washington and published in 1998 in the journal Nature, demonstrated that double-stranded RNA could trigger the silencing of specific genes in the nematode Caenorhabditis elegans.[2] The discovery opened entirely new avenues for understanding gene regulation and has had far-reaching implications for biomedical research, including the development of potential therapies for diseases ranging from viral infections to cancer. Fire has spent much of his career studying the mechanisms of gene expression and gene silencing, first at Johns Hopkins University, then at Stanford, where he has continued to contribute to the understanding of molecular genetics.
Early Life
Andrew Zachary Fire was born on April 27, 1959, in Palo Alto, California.[3] His birth in Palo Alto placed him at the geographic center of what would become Silicon Valley, and in immediate proximity to Stanford University, the institution with which he would later become most closely associated. A Stanford Report article, published upon the announcement of his Nobel Prize, noted with some humor that "Andrew Fire took his first look around at Stanford and started screaming," referring to the fact that he was born in the Stanford area—his initial response being that of any newborn.[4]
Fire demonstrated an early interest in science and learning. In 2025, he donated a library card dating back to the 1970s to the Nobel Prize Museum in Stockholm, Sweden, a gesture that reflected the importance of reading and self-directed learning during his formative years.[5] The donation of this well-used card to a major museum underscored Fire's belief in the value of curiosity and access to knowledge as formative influences for young scientists. Growing up in the intellectually vibrant environment of the San Francisco Bay Area, Fire was exposed to a culture of scientific inquiry and academic excellence from an early age.
Education
Fire pursued his undergraduate education at the University of California, Berkeley, where he earned a Bachelor of Arts degree in mathematics.[3] He subsequently enrolled in graduate studies at the Massachusetts Institute of Technology (MIT), one of the premier research universities in the world. At MIT, Fire conducted his doctoral research under the supervision of Phillip Allen Sharp, a distinguished molecular biologist who would himself receive the Nobel Prize in Physiology or Medicine in 1993 for the discovery of gene splicing. Fire completed his Ph.D. in 1983 with a dissertation titled "In vitro transcription studies of adenovirus."[3] His doctoral work focused on the mechanisms of transcription—the process by which genetic information encoded in DNA is copied into RNA—providing him with a strong foundation in molecular biology that would prove essential to his later groundbreaking research.
After completing his doctorate, Fire undertook postdoctoral research at the MRC Laboratory of Molecular Biology in Cambridge, England, a renowned institution that has been the workplace of numerous Nobel laureates.[3] This period further refined his expertise in genetic research and molecular biology, and it was during this time that he began to develop his interest in the model organism Caenorhabditis elegans, a small nematode worm that has been instrumental in many major biological discoveries.
Career
Carnegie Institution and Johns Hopkins University
Following his postdoctoral work in Cambridge, Fire joined the staff of the Carnegie Institution of Washington's Department of Embryology in Baltimore, Maryland.[3] At the Carnegie Institution, he established an independent research program focused on understanding gene expression and gene regulation in C. elegans. The nematode, with its relatively simple body plan, fully sequenced genome, and well-characterized developmental biology, provided an ideal system for investigating the molecular mechanisms that control how genes are turned on and off.
During this period, Fire also held an adjunct faculty position at Johns Hopkins University, one of the leading research universities in the United States, further embedding himself in Baltimore's robust biomedical research community. It was at the Carnegie Institution that Fire would carry out the research that would ultimately lead to his Nobel Prize.
Discovery of RNA Interference
The discovery for which Fire is best known—RNA interference, or RNAi—was made in collaboration with Craig C. Mello, who was then at the University of Massachusetts Medical School. Their seminal paper, "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans," was published in the journal Nature on February 19, 1998.[2][6]
The key finding of their research was that double-stranded RNA (dsRNA)—a form of RNA in which two complementary strands are paired together—could silence specific genes with remarkable potency and precision. Prior to their work, scientists had known that injecting single-stranded RNA molecules—either sense or antisense strands—into C. elegans could produce modest effects on gene expression. However, Fire and Mello made the critical observation that when they injected double-stranded RNA corresponding to a particular gene, the silencing effect was dramatically more powerful than that produced by either strand alone.[2]
As the Nobel Committee described it, Fire and Mello discovered "a fundamental mechanism for controlling the flow of genetic information."[1] The double-stranded RNA triggered a cellular process in which the corresponding messenger RNA (mRNA) was degraded, effectively preventing the gene from being translated into protein. This process was not only highly specific—targeting only the gene matching the dsRNA sequence—but also remarkably efficient, requiring only small amounts of dsRNA to achieve substantial gene silencing.[2]
The implications of the discovery were immediate and far-reaching. RNAi was quickly recognized as a naturally occurring biological mechanism, present not only in nematodes but across a wide range of organisms, including plants, insects, and mammals. The discovery revealed that cells possess an ancient and conserved defense mechanism that likely evolved to protect against viral infections and to regulate the activity of mobile genetic elements known as transposons. Furthermore, RNAi provided researchers with a powerful new tool for studying gene function: by designing specific dsRNA molecules, scientists could selectively silence virtually any gene and observe the resulting effects, thereby determining the gene's role in biological processes.[2]
The potential therapeutic applications of RNAi also attracted enormous attention from the pharmaceutical and biotechnology industries. The ability to selectively silence disease-causing genes raised the possibility of developing a new class of medicines for conditions including viral infections, cardiovascular disease, cancer, and various genetic disorders. The Nobel Committee noted that RNAi was "already being widely used in basic science as a method to study the function of genes" and was "expected to lead to novel medical applications in the future."[1]
Stanford University
In 2003, Fire left the Carnegie Institution to join the faculty of the Stanford University School of Medicine, where he was appointed Professor of Pathology and of Genetics.[4] At Stanford, he continued his research into the mechanisms of gene regulation and RNA biology, building on the foundational work that had led to the discovery of RNAi. His return to the Palo Alto area, where he had been born, brought his career full circle.
At Stanford, Fire has led a research laboratory that investigates a range of questions related to gene expression, RNA biology, and the mechanisms by which organisms respond to foreign or aberrant nucleic acids. His work has continued to explore the biological roles of small RNA molecules and the pathways through which cells detect and respond to double-stranded RNA. The Fire laboratory has employed C. elegans as a primary model organism while also extending investigations to other experimental systems.
Fire's appointment at Stanford placed him among a distinguished community of molecular biologists and geneticists, and the university has provided a supportive environment for his continued contributions to the field. His presence at the Stanford School of Medicine has also enriched the training of graduate students and postdoctoral researchers who have passed through his laboratory.
Continued Research and Public Engagement
Beyond his laboratory research, Fire has been engaged in broader scientific and educational activities. In a 2006 interview conducted by Adam Smith on behalf of the Nobel Foundation, Fire and Mello discussed the circumstances of their discovery, the collaborative nature of their research, and the broader implications of RNAi for biology and medicine.[7]
Fire has also demonstrated a commitment to promoting scientific literacy and the value of intellectual curiosity. His donation of a 1970s-era library card to the Nobel Prize Museum in Stockholm in 2025 was described by the museum as a meaningful artifact reflecting the importance of access to knowledge and the role of self-directed learning in the development of scientists.[5] The gesture illustrated Fire's belief that the foundations of scientific achievement are often laid long before formal research begins, through habits of reading and inquiry cultivated in youth.
Recognition
Nobel Prize in Physiology or Medicine
On October 2, 2006, the Nobel Assembly at Karolinska Institutet announced that Andrew Z. Fire and Craig C. Mello had been awarded the Nobel Prize in Physiology or Medicine "for their discovery of RNA interference – gene silencing by double-stranded RNA."[1] The prize recognized their 1998 Nature paper as a landmark contribution to the understanding of gene regulation. The Nobel Committee described RNAi as "a fundamental mechanism for controlling the flow of genetic information" and noted that the discovery had "already opened up new possibilities in medicine."[1]
The speed with which the Nobel Committee recognized Fire and Mello's work was notable. The prize was awarded only eight years after the publication of their key paper, reflecting the exceptional impact that RNAi had on biological research in a relatively short period. As the popular information document accompanying the prize stated, the discovery "clarified many previously unexplained observations and revealed a natural mechanism for controlling the flow of genetic information."[2]
Fire shared the prize equally with Mello. At the time of the announcement, Fire was 47 years old and already established at Stanford University. The Stanford Report covered the announcement extensively, noting Fire's Palo Alto origins and his career trajectory from birth in the area to his appointment at the university's School of Medicine.[4]
Other Honors
Fire has received numerous additional honors and distinctions throughout his career, recognizing his contributions to molecular biology and genetics. The Britannica encyclopedia identifies him as one of the notable American scientists of his generation.[3] He holds a position as a member of the scientific community whose work has been widely cited and has influenced multiple areas of biological and medical research.
Legacy
The discovery of RNA interference by Andrew Fire and Craig Mello has had a profound and lasting impact on the biological sciences and on medicine. RNAi provided researchers with an unprecedented tool for studying gene function. By allowing scientists to selectively silence individual genes and observe the resulting phenotypic effects, RNAi became an indispensable method in genetics, developmental biology, and many other fields. The technique accelerated the pace of genetic research and contributed to the functional annotation of genomes across numerous species.[2]
In medicine, the principles of RNAi have been translated into therapeutic applications. The ability to silence disease-associated genes using small interfering RNA (siRNA) molecules opened a new frontier in drug development. Researchers and pharmaceutical companies have pursued RNAi-based therapies for a range of conditions, including hereditary diseases, viral infections, and cancers. The first RNAi therapeutic, patisiran, was approved by the U.S. Food and Drug Administration in 2018 for the treatment of hereditary transthyretin-mediated amyloidosis, validating the therapeutic potential of the mechanism that Fire and Mello had first described in nematodes two decades earlier.
Fire's contributions to science extend beyond the single discovery of RNAi. His career has exemplified the value of basic research conducted in model organisms—work that may initially appear far removed from clinical applications but that can yield insights of fundamental importance to human health. The use of C. elegans as a model system, a tradition established by Sydney Brenner and continued by researchers like Fire, has repeatedly demonstrated the power of simple organisms to illuminate universal biological principles.
Andrew Fire's legacy is also reflected in the generations of scientists he has trained and mentored at the Carnegie Institution, Johns Hopkins University, and Stanford University. His research group has contributed to the understanding of RNA biology, gene regulation, and the mechanisms by which organisms defend themselves against foreign nucleic acids.
The donation of his childhood library card to the Nobel Prize Museum serves as a fitting symbol of Fire's broader legacy: a reminder that the path to scientific discovery often begins with curiosity, reading, and an eagerness to learn.[5]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Press release: The Nobel Prize in Physiology or Medicine 2006".NobelPrize.org.October 2, 2006.https://www.nobelprize.org/prizes/medicine/2006/press-release/.Retrieved 2026-02-24.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 "The Nobel Prize in Physiology or Medicine 2006 - Popular information".NobelPrize.org.August 17, 2018.https://www.nobelprize.org/prizes/medicine/2006/popular-information/.Retrieved 2026-02-24.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 "Andrew Z. Fire".Britannica.December 24, 2025.https://www.britannica.com/biography/Andrew-Fire.Retrieved 2026-02-24.
- ↑ 4.0 4.1 4.2 "Andrew Fire shares Nobel Prize for discovering how RNA can switch off genes".Stanford Report.October 11, 2006.https://news.stanford.edu/stories/2006/10/andrew-fire-shares-nobel-prize-discovering-rna-can-switch-off-genes.Retrieved 2026-02-24.
- ↑ 5.0 5.1 5.2 "Well-used library card donated to the Nobel Prize Museum".NobelPrize.org.May 13, 2025.https://www.nobelprize.org/press-release/well-used-library-card-donated-to-the-nobel-prize-museum/.Retrieved 2026-02-24.
- ↑ "1998Natur.391..806F".Astrophysics Data System.https://ui.adsabs.harvard.edu/abs/1998Natur.391..806F.Retrieved 2026-02-24.
- ↑ "Transcript from an interview with the 2006 medicine laureates".NobelPrize.org.November 19, 2024.https://www.nobelprize.org/prizes/medicine/2006/fire/224659-medicine-laureates-interview-transcript/.Retrieved 2026-02-24.
- 1959 births
- Living people
- American biologists
- American geneticists
- American Nobel laureates
- Nobel laureates in Physiology or Medicine
- People from Palo Alto, California
- University of California, Berkeley alumni
- Massachusetts Institute of Technology alumni
- Stanford University School of Medicine faculty
- Johns Hopkins University faculty
- Carnegie Institution for Science people
- RNA interference
- Molecular biologists
- Members of the National Academy of Sciences